Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Rapport Therapeutics, Inc.

RAPP · Nasdaq · CIK 0002012593 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

33 Form 4 transaction lines observed in the same window
33 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2025-09-12 · Huber Reid M · $499.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ceesay AbrahamChief Executive Officer
▼▼▼▼▼▼▼▼▼▼
TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwner
▼▼▼▼
Yeleswaram KrishnaswamyChief Development Officer
▼▼▼
Gault CherylChief Operating Officer
▼▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-09-12 · Huber Reid M.

Recent Form 4 activity

0Purchases
71Sales
4Other Form 4 lines
33SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING33 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,194,008
Previous report
2,248,069
Avg daily volume
660,098
Days to cover
4.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-09-12PAUL STEVEN MPurchase (P)Common Stock41,666USD 24.65USD 1,027,107SEC filing ↗
2025-09-12Huber Reid MPurchase (P)Common Stock20,400USD 24.48USD 499,392SEC filing ↗
2025-09-11Young Wendy B.Purchase (P)Common Stock3,500USD 22.60USD 79,100SEC filing ↗
2025-03-13Ignelzi Troy A.Purchase (P)Common Stock100USD 9.98USD 998SEC filing ↗
2025-03-12Young Wendy B.Purchase (P)Common Stock6,000USD 10.21USD 61,260SEC filing ↗
2025-03-12Ignelzi Troy A.Purchase (P)Common Stock9,900USD 10.10USD 99,990SEC filing ↗
2024-07-01HEALY JAMESPurchase (P)Common Stock44,032USD 24.52USD 1,079,703SEC filing ↗
2024-06-10HEALY JAMESPurchase (P)Common Stock558,824USD 17.00USD 9,500,008SEC filing ↗

Form 4 evidence

75 transaction lines in the latest 365-day window; 125 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-07Ceesay AbrahamSale (S)Common Stock1,147USD 30.66USD 35,167SEC filing ↗
2026-10-06Ceesay AbrahamSale (S)Common Stock3,375USD 32.03USD 108,106SEC filing ↗
2026-09-30Gault CherylSale (S)Common Stock10,000USD 33.19USD 331,856SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-07Ceesay AbrahamSale (S)Common Stock1,147USD 30.66USD 35,167SEC filing ↗
2026-10-06Ceesay AbrahamSale (S)Common Stock3,375USD 32.03USD 108,106SEC filing ↗
2026-09-30Gault CherylSale (S)Common Stock10,000USD 33.19USD 331,856SEC filing ↗
2026-09-23Ceesay AbrahamSale (S)Common Stock2,210USD 39.17USD 86,561SEC filing ↗
2026-09-08Ceesay AbrahamSale (S)Common Stock8,210USD 45.62USD 374,529SEC filing ↗
2026-08-25Yeleswaram KrishnaswamySale (S)Common Stock37,000USD 50.64USD 1,873,621SEC filing ↗
2026-08-25Ceesay AbrahamSale (S)Common Stock18,921USD 49.57USD 937,914SEC filing ↗
2026-08-24Yeleswaram KrishnaswamySale (S)Common Stock13,160USD 50.00USD 658,000SEC filing ↗
2026-08-19Yeleswaram KrishnaswamySale (S)Common Stock404USD 49.90USD 20,160SEC filing ↗
2026-08-11Ceesay AbrahamSale (S)Common Stock28,958USD 48.01USD 1,390,326SEC filing ↗
2026-08-10Ceesay AbrahamSale (S)Common Stock22,541USD 46.26USD 1,042,738SEC filing ↗
2026-07-27Ceesay AbrahamSale (S)Common Stock2,210USD 42.11USD 93,068SEC filing ↗
2026-07-14Ceesay AbrahamSale (S)Common Stock8,210USD 40.00USD 328,421SEC filing ↗
2026-06-30Gault CherylSale (S)Common Stock10,000USD 41.58USD 415,770SEC filing ↗
2026-06-29Ceesay AbrahamSale (S)Common Stock8,220USD 39.83USD 327,409SEC filing ↗
2026-05-26TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Sale (S)Common Stock18,572USD 40.05USD 743,809SEC filing ↗
2026-05-11TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Sale (S)Common Stock133,618USD 40.24USD 5,376,788SEC filing ↗
2026-05-08TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Sale (S)Common Stock5,018USD 40.31USD 202,276SEC filing ↗
2026-05-07TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Sale (S)Common Stock271,495USD 40.12USD 10,892,379SEC filing ↗
2026-04-17Yeleswaram KrishnaswamySale (S)Common Stock20,225USD 39.99USD 808,798SEC filing ↗
2026-04-17TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Sale (S)Common Stock426,005USD 40.32USD 17,176,522SEC filing ↗
2026-04-14Yeleswaram KrishnaswamySale (S)Common Stock10,200USD 35.08USD 357,816SEC filing ↗
2026-04-13Yeleswaram KrishnaswamySale (S)Common Stock9,165USD 34.97USD 320,500SEC filing ↗
2026-04-10Yeleswaram KrishnaswamySale (S)Common Stock500USD 34.98USD 17,490SEC filing ↗
2026-04-08Yeleswaram KrishnaswamySale (S)Common Stock360USD 34.90USD 12,564SEC filing ↗
2026-03-30Gault CherylSale (S)Common Stock10,000USD 28.18USD 281,848SEC filing ↗
2026-03-25Yeleswaram KrishnaswamySale (S)Common Stock10,115USD 29.99USD 303,349SEC filing ↗
2026-03-05Gault CherylSale (S)Common Stock2,014USD 28.93USD 58,265SEC filing ↗
2026-02-19Bredt DavidOption exercise / conversion (M)Common Stock6,000USD 1.80USD 10,800SEC filing ↗
2026-02-18Ceesay AbrahamSale (S)Common Stock10,916USD 29.35USD 320,366SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRAPP
CIK0002012593
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history125 transaction lines from 2024-06-10 to 2026-10-07
24 P purchase lines · 91 S sale lines · 10 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.